CQDM and Esphera SynBio Announce New Project to Advance Next Generation mRNA Vaccine Development, supported by the CQDM Quantum Leap program

Announcement OTTAWA, Ontario – Jan. 9, 2025 – Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its proprietary technology, Esphera SynBio causes the production of modified nanomedicines within patients upon delivery of LNP/mRNA vaccines. These in situ produced nanomedicines can have precise targeting…

New hire,Lina Chaya, Administration Coordinator 

Welcome to Lina Chaya, our new Administration Coordinator! With a Master’s degree in Administration and a specialization in Public Management from ÉNAP, she brings extensive administrative experience gained in both public and private organizations, in Quebec and Lebanon.Lina has notably held various roles in analysis, management, and coordination at Desjardins, CNESST, and HEC Montréal. 🌟…

Call for Ideas: AI-assisted protein design

Call for Ideas: AI-assisted protein design CQDM is pleased to launch a call for ideas for our upcoming CQDM Connect-Pharma: Pitch Day. We are searching for world-class research on AI-assisted protein design to present to domain experts from leading global pharmaceutical organizations on March 5, 2025.Our objective is to bring ground-breaking, innovative Canadian research to…

CQDM and Novatek International are funding the validation of a new therapeutic solution to treat mild cognitive impairment remotely

Announcement Montréal, December 10th, 2024 – CQDM is pleased to announce the funding of a collaborative research project between Novatek International and the National Research Council of Canada (NRC). The collaboration will leverage the expertise of NRC researchers, Vincent Gagnon Shaigetz and Nushi Choudhury, in virtual reality software development for cognitive health. Together, the project…

CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research

Announcement Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at McGill University, aimed at funding translational research projects carried out through collaborations between researchers and industry. This alliance seeks to support and accelerate the development and commercialization of innovative RNA-based therapies. It aims to…

CQDM present at NeuroSphere

CQDM attended NeuroSphere Demo Day on November 8. Mathieu Paquette, Ph.D., M.B.A., Director of Business Development and Quebec Team Lead, who supports numerous startups daily, shared his experience on a panel discussing “The Path to Commercialization for Impact-Oriented Startups.”Simon Fournier, MSc, MBA, also Director of Business Development at CQDM, had the opportunity to present CQDM’s…

New hire Jeanne Ouellet-Ayotte, Marketing & Communication Coordinator

We are thrilled to welcome Jeanne Ouellet-Ayotte, our new Marketing and Communications Coordinator! With a background in photography and graphic design, Jeanne specializes in branding, combining creative conceptualization with strategic positioning to maximize marketing campaign impact. Over the past ten years, she has worked independently as an art director, collaborating with prestigious clients such as…